BC
Bradley Canino Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
87.5%
Neutral
12.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $36 |
44%
upside
| 2 | +23% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +22% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $38 |
176%
upside
| 1 | -4.5% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $155 |
49%
upside
| 1 | +16% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $7 |
298%
upside
| 1 | +53% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Buy
Assumed
| $90 |
29%
upside
| 1 | +12% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $40 |
135%
upside
| 1 | -15% |
0
%
| 22 Oct ‘25 2 months ago |
|